(Q37806320)

23 August 2017

title

NMDA receptor antagonists for the treatment of neuropathic pain (English)

1 reference

23 August 2017

0 references

Susan Collins

1

1 reference

23 August 2017

Marnix J Sigtermans

2

1 reference

23 August 2017

Albert Dahan

3

1 reference

23 August 2017

Wouter W A Zuurmond

4

1 reference

23 August 2017

Roberto S G M Perez

5

1 reference

23 August 2017

language of work or name

1 reference

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

1726-1742

1 reference

The Kyoto protocol of IASP Basic Pain Terminology

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Mechanisms of Disease: neuropathic pain—a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Neuropathic central pain: epidemiology, etiology, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Glutamate receptors and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

How to select, calculate, and interpret effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Dextromethorphan for phantom pain attenuation in cancer amputees: a double-blind crossover trial involving three patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Efficacy of intravenous magnesium in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Dextromethorphan mitigates phantom pain in cancer amputees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Analgesic effect of dextromethorphan in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Short- and long-term efficacy of oral ketamine in eight chronic-pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

The chemical biology of clinically tolerated NMDA receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

NMDA receptor subunits: function and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Confidence intervals for the overall effect size in random-effects meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.00981.X

Ergonomic and physiotherapeutic interventions for treating work-related complaints of the arm, neck or shoulder in adults

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003471.PUB3

Identifiers

DOI

10.1111/J.1526-4637.2010.00981.X

1 reference

23 August 2017

1 reference